APA

Ke C., Luo J., Cen Z., Li Y., Cai H., Wang J., Chen F., Siegel E. R., Le K. N., Winokan J. R., Gibson G. J., McSwain A. E., Afrasiabi K., Linskey M. E., Zhou Y., Chen Z. & Zhou Y. (20200316). Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma. : Cancer science.

Chicago

Ke Chao, Luo Jun-Ran, Cen Zi-Wen, Li Yanyan, Cai Hai-Ping, Wang Jing, Chen Fu-Rong, Siegel Eric R, Le Kody N, Winokan Jesica R, Gibson Grace J, McSwain Asia E, Afrasiabi Kambiz, Linskey Mark E, Zhou You-Xin, Chen Zhong-Ping and Zhou Yi-Hong. 20200316. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma. : Cancer science.

Harvard

Ke C., Luo J., Cen Z., Li Y., Cai H., Wang J., Chen F., Siegel E. R., Le K. N., Winokan J. R., Gibson G. J., McSwain A. E., Afrasiabi K., Linskey M. E., Zhou Y., Chen Z. and Zhou Y. (20200316). Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma. : Cancer science.

MLA

Ke Chao, Luo Jun-Ran, Cen Zi-Wen, Li Yanyan, Cai Hai-Ping, Wang Jing, Chen Fu-Rong, Siegel Eric R, Le Kody N, Winokan Jesica R, Gibson Grace J, McSwain Asia E, Afrasiabi Kambiz, Linskey Mark E, Zhou You-Xin, Chen Zhong-Ping and Zhou Yi-Hong. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma. : Cancer science. 20200316.